Tristan T. Timbrook

Tristan T. Timbrook, PharmD, MBA, BCPS

Academic Information

Departments Adjunct - Pharmacotherapy

Board Certification

  • Board of Pharmacy Specialties (Sub: Pharmacotherapy)

Experienced antimicrobial stewardship pharmacist and outcomes researcher with a demonstrated history of working in the hospital & health care industry. Skilled in infectious diseases, molecular microbiology, outcomes modeling, and epidemiology. Research focus on comparative effectiveness and safety research, antimicrobial stewardship initiatives, big data, and understanding the relationship between microbiology diagnostics and clinical outcomes

Education History

Undergraduate University of Louisville
 BA
Graduate Training Sullivan University
 MBA
Doctoral Training Sullivan University College of Pharmacy
 PharmD
Residency Medical University of South Carolina
 Resident
Residency Medical University of South Carolina
 Resident
Fellowship University of Rhode Island
 Fellow
Graduate Training University of Florida
 MSci

Selected Publications

Journal Article

  1. Caffrey AR, Timbrook TT, Noh E, Sakoulas G, Opal SM, Nizet V, LaPlante KL (2017). Evidence To Support Continuation of Statin Therapy in Patients with Staphylococcus aureus Bacteremia. Antimicrob Agents Chemother, 61(3). (Read full article)
  2. Parente DM, Cunha CB, Mylonakis E, Timbrook TT (2019). Reply to Burnham, Kakol, and Vazquez-Guillamet. Clin Infect Dis, 68(7), 1251-1252. (Read full article)
  3. Parente DM, Cunha CB, Mylonakis E, Timbrook TT (2018). The Clinical Utility of Methicillin-Resistant Staphylococcus aureus (MRSA) Nasal Screening to Rule Out MRSA Pneumonia: A Diagnostic Meta-analysis With Antimicrobial Stewardship Implications. Clin Infect Dis, 67(1), 1-7. (Read full article)
  4. Timbrook TT, Morton JB, McConeghy KW, Caffrey AR, Mylonakis E, LaPlante KL (2017). The Effect of Molecular Rapid Diagnostic Testing on Clinical Outcomes in Bloodstream Infections: A Systematic Review and Meta-analysis. Clin Infect Dis, 64(1), 15-23. (Read full article)
  5. Luther MK, Timbrook TT, Caffrey AR, Dosa D, Lodise TP, LaPlante K (2018). Vancomycin Plus Piperacillin-Tazobactam and Acute Kidney Injury in Adults: A Systematic Review and Meta-Analysis. Critical care medicine, 46(1), 12-20. (Read full article)
  6. Timbrook TT, Hurst JM, Bosso J (2016). Impact of an Antimicrobial Stewardship Program on Antimicrobial Utilization, Bacterial Susceptibilities, and Financial Expenditures at an Academic Medical Center. Hospital pharmacy, 51(9), 703-711. (Read full article)
  7. Appaneal HJ, Luther MK, Timbrook TT, LaPlante KL, Dosa D (2019). Facilitators and Barriers to Antibiotic Stewardship: A Qualitative Study of Pharmacists' Perspectives. Hospital pharmacy, 54(4), 250-258. (Read full article)
  8. Timbrook T, Boger MS, Steed LL, Hurst J (2015). Unanticipated Multiplex PCR-Based Identification of Polymicrobial Blood Culture Resulting in Earlier Isolation, Determination of Susceptibilities, and Optimization of Clinical Care. Journal of clinical microbiology, 53(7), 2371-3. (Read full article)
  9. Timbrook TT, Spivak ES, Hanson K (2018). Current and Future Opportunities for Rapid Diagnostics in Antimicrobial Stewardship. The Medical clinics of North America, 102(5), 899-911. (Read full article)
  10. Timbrook TT, Caffrey AR, Luther MK, Lopes V, LaPlante K (2018). Association of Higher Daptomycin Dose (7 mg/kg or Greater) with Improved Survival in Patients with Methicillin-Resistant Staphylococcus aureus Bacteremia. Pharmacotherapy, 38(2), 189-196. (Read full article)
  11. Griffin AT, Timbrook T, Harting J, Christensen (2013). Streptococcus anginosus group and osteomyelitis: a single centre clinical experience. Postgraduate medical journal, 89(1051), 262-5. (Read full article)
  12. Wenzler E, Timbrook TT, Wong JR, Hurst JM, MacVane S (2018). Implementation and optimization of molecular rapid diagnostic tests for bloodstream infections. American journal of health-system pharmacy, 75(16), 1191-1202. (Read full article)
  13. Caffrey AR, Babcock ZR, Lopes VV, Timbrook TT, LaPlante K (2019). Heterogeneity in the treatment of bloodstream infections identified from antibiotic exposure mapping. Pharmacoepidemiology and drug safety, 28(5), 707-715. (Read full article)
  14. Caffrey AR, Timbrook TT, Ali SR, Nizet V, Sakoulas (2019). Proton-pump inhibitors do not influence clinical outcomes in patients with Staphylococcus aureus bacteremia. Therapeutic advances in gastroenterology, 12, 1756284819834273. (Read full article)
  15. Parente DM, Timbrook TT, Caffrey AR, LaPlante K (2017). Inappropriate prescribing in outpatient healthcare: an evaluation of respiratory infection visits among veterans in teaching versus non-teaching primary care clinics. Antimicrobial resistance and infection control, 6, 33. (Read full article)
  16. Timbrook TT, Burnham J (2019). Power Calculations, Effect Sizes, and 30-Day Mortality in Enterobacteriaceae Bacteremia. JAMA internal medicine, 179(6), 849-850. (Read full article)
  17. Pawar AM, LaPlante KL, Timbrook TT, Caffrey A (2018). Optimal duration for continuation of statin therapy in bacteremic patients. Therapeutic advances in infectious disease, 5(5), 83-90. (Read full article)
  18. Pawar AM, LaPlante KL, Timbrook TT, Caffrey A (2018). Improved survival with continuation of statins in bacteremic patients. SAGE open medicine, 6, 2050312118801707. (Read full article)
  19. Timbrook TT, Caffrey AR, Ovalle A, Beganovic M, Curioso W, Gaitanis M, LaPlante K (2017). Assessments of Opportunities to Improve Antibiotic Prescribing in an Emergency Department: A Period Prevalence Survey. Infectious diseases and therapy, 6(4), 497-505. (Read full article)
  20. Timbrook T, Maxam M, Bosso (2015). Antibiotic Discontinuation Rates Associated with Positive Respiratory Viral Panel and Low Procalcitonin Results in Proven or Suspected Respiratory Infections. Infectious diseases and therapy, 4(3), 297-306. (Read full article)
  21. Ihm C, Sutton JD, Timbrook TT, Spivak E (2019). Treatment Duration and Associated Outcomes for Skin and Soft Tissue Infections in Patients With Obesity or Heart Failure. Open forum infectious diseases, 6(6), ofz217. (Read full article)
  22. Beganovic M, Timbrook TT, Wieczorkiewicz S (2018). Predictors of Time to Effective and Optimal Antimicrobial Therapy in Patients With Positive Blood Cultures Identified via Molecular Rapid Diagnostic Testing. Open forum infectious diseases, 6(1), ofy350. (Read full article)